Annual Short Term Debt
$1.51 M
+$294.00 K+24.08%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual short term debt is $1.51 million, with the most recent change of +$294.00 thousand (+24.08%) on December 31, 2022.
- During the last 3 years, NLTX annual short term debt has risen by +$897.00 thousand (+145.15%).
Performance
NLTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$1.55 M
+$61.00 K+4.09%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly short term debt is $1.55 million, with the most recent change of +$61.00 thousand (+4.09%) on September 30, 2023.
- Over the past year, NLTX quarterly short term debt has increased by +$175.00 thousand (+12.69%).
Performance
NLTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NLTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.1% | +12.7% |
| 3 y3 years | +145.2% | +320.0% |
| 5 y5 years | - | - |
NLTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -19.4% | -10.4% | -21.4% |
| 5 y | 5-year | at high | -59.2% | -10.4% | -80.3% |
| alltime | all time | at high | -99.4% | -10.4% | -99.4% |
Neoleukin Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.55 M(+4.1%) |
| Jun 2023 | - | $1.49 M(-13.9%) |
| Mar 2023 | - | $1.74 M(+14.5%) |
| Dec 2022 | $1.51 M(+24.1%) | $1.51 M(+9.9%) |
| Sep 2022 | - | $1.38 M(-0.4%) |
| Jun 2022 | - | $1.39 M(+9.0%) |
| Mar 2022 | - | $1.27 M(+4.1%) |
| Dec 2021 | $1.22 M | $1.22 M(-0.1%) |
| Sep 2021 | - | $1.22 M(+3.8%) |
| Jun 2021 | - | $1.18 M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.10 M(+55.2%) |
| Dec 2020 | $708.00 K(+14.6%) | $708.00 K(+91.4%) |
| Sep 2020 | - | $370.00 K(+20.9%) |
| Jun 2020 | - | $306.00 K(-49.0%) |
| Mar 2020 | - | $600.00 K(-2.9%) |
| Dec 2019 | $618.00 K(+6766.7%) | $618.00 K(+133.2%) |
| Sep 2019 | - | $265.00 K(+31.8%) |
| Jun 2019 | - | $201.00 K(+0.5%) |
| Mar 2019 | - | $200.00 K(+2122.2%) |
| Dec 2018 | $9000.00(-96.4%) | $9000.00(-96.4%) |
| Dec 2013 | $250.00 K | $250.00 K |
FAQ
- What is Neoleukin Therapeutics annual short term debt?
- What is the all time high annual short term debt for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual short term debt year-on-year change?
- What is Neoleukin Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly short term debt year-on-year change?
What is Neoleukin Therapeutics annual short term debt?
The current annual short term debt of NLTX is $1.51 M
What is the all time high annual short term debt for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual short term debt is $1.51 M
What is Neoleukin Therapeutics annual short term debt year-on-year change?
Over the past year, NLTX annual short term debt has changed by +$294.00 K (+24.08%)
What is Neoleukin Therapeutics quarterly short term debt?
The current quarterly short term debt of NLTX is $1.55 M
What is the all time high quarterly short term debt for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly short term debt is $1.74 M
What is Neoleukin Therapeutics quarterly short term debt year-on-year change?
Over the past year, NLTX quarterly short term debt has changed by +$175.00 K (+12.69%)